Pfizer's quarterly profit declined to $2.59 billion, or $0.39 per share, versus a year-ago profit of $3.21 billion, or $0.43 per share, in the year-earlier period. Its adjusted earnings climbed 16 percent to $0.58 per share.
Its revenue fell 2 percent to $12.64 billion from $12.95 billion. However, analysts were projecting earnings of $0.56 per share on revenue of $12.7 billion. Pfizer lowered its 2013 earnings view to $3.05 to $3.15 per share, versus its earlier forecast of $3.07 to $3.22 per share.
Equities Trading UPShares of Pitney Bowes PBI got a boost, shooting up 10.55 percent to $21.27 after the company reported an upbeat Q3 profit.
UBS AG UBS shares tumbled 7.16 percent to $19.84 on Q3 results.
Commodities
In commodity news, oil traded down 0.39 percent to $98.30, while gold traded down 0.38 percent to $1,347.10.
Silver traded up 0.05 percent Tuesday to $22.55, while copper rose 0.55 percent to $3.29.
The US producer price index declined 0.1 percent in September, while core wholesale prices climbed 0.1 percent. However, economists were expecting a 0.3 percent gain in the overall PPI and a 0.1 percent increase in the core PPI.
The S&P/Case-Shiller home price index rose 12.82 percent y/y in August, versus a 12.40 percent growth in July. However, economists were expecting a 12.50 percent rise.
The Conference Board's consumer confidence index fell to 71.20 in October, from a prior reading of 79.70. However, economists were expecting a reading of 75.00.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.